| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |